Please Wait...

Michael W. Weiner

Translation skills

Main profile

Michael W. Weiner, MD
Senior Scientific Advisor

Michael Weiner, MD, is a Professor in Residence in Radiology and Biomedical Engineering, Medicine, Psychiatry, and Neurology at the University of California, San Francisco.  He is Principle Investigator of the Alzheimer's Disease Neuroimaging Initiative (ADNI) and served as the Director of the Center for Imaging of Neurodegenerative Diseases (CIND) at the San Francisco Veterans Affairs Medical Center for nearly 10 years.

After graduating from the Johns Hopkins University in 1961, He obtained his MD from SUNY Upstate Medical Center in Syracuse, New York in 1965, and he completed his internship and residency in Medicine from Mt. Sinai Hospital in 1967.  From 1967-1968, Dr. Weiner completed a residency and clinical fellowship in Metabolism from Yale-New Haven Medical Center.  In 1970, he completed a research fellowship in Nephrology from Yale University School of Medicine and a research fellowship in Biochemistry from the University of Wisconsin Institute for Enzyme Research in 1972, followed by a joint appointment in the Department of Medicine; Renal Section from the University of Wisconsin Institute in 1972.  In 1974 he became an Assistant Professor of Medicine (Nephrology) at Stanford University, and in 1980 he became an Associate Professor of Medicine (Nephrology) at UCSF.  In 1983 he established the Magnetic Resonance Unit at the San Francisco VA Medical Center, which became the Center for Imaging of Neurodegenerative Diseases in 2004.  In 1990 he became a Professor of Radiology, Medicine, Psychiatry and Neurology at UCSF.

Dr. Weiner's research activities involve the development and utilization of MRI and PET for investigating and diagnosing neurodegenerative diseases.  In 1980, Dr. Weiner was one of the first to perform MRS on an intact animal, and subsequently pursued his goal to develop MRI/S as a clinical tool.  Over the past 25 years, he has worked to develop and optimize the use of MRI, PET, and blood based biomarker methods to diagnose Alzheimer's disease and other neurodegenerative disorders.

Dr. Weiner's research focuses on monitoring effects of treatment to slow progressions in Alzheimer's disease and the early detection of Alzheimer's disease in patients.  He has also launched The Brain Health Registry, which is a web-based registry for recruiting, screening, and longitudinally monitoring subjects for neuroscience studies of all types.  Dr. Weiner has over 650 published articles and has authored over 70 book chapters.

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Thanks everyone who joined us in today's webinar! https://t.co/Wp6D0oLfc3
Bioclinica (1 hour ago)
Kicking off at 11 EST!! https://t.co/v4hMLK9oAZ
Bioclinica (3 hours ago)
BREAKING: Bioclinica Launches NAFLD/NASH Clinical Trials Practice. Helps sponsors apply medical imaging in trials t… https://t.co/JLTxoevbXU
Bioclinica (6 hours ago)
BREAKING: Bioclinica launches #NAFLD #NASH clinical trials practice, helping sponsors apply medical imaging in tria… https://t.co/eUy34LiSAd
Bioclinica (8 hours ago)
Attending the #NASH Summit next week? If so, drop by @bioclinica's exhibit to learn how medical imaging is being u… https://t.co/TNkl7ce4Sq
Bioclinica (Yesterday)
RT @bioclinica: Sponsors conducting clinical trials in #NAFLD or #NASH are invited to join us in an upcoming webinar exploring the use of n…
Bioclinica (Yesterday)

Latest Blogs:

Site Payments Solutions
Nonalcoholic steatohepatitis (NASH) development programs
Dr. Joby John
Transformational Trends in Investigator Site Payments
Clinical Supply Chain Success: Leveraging Technology
Blood pressure monitor
Prescription box